Compare SPT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPT | TMDX |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.6M | 4.6B |
| IPO Year | 2019 | 2019 |
| Metric | SPT | TMDX |
|---|---|---|
| Price | $5.51 | $99.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $12.38 | ★ $154.00 |
| AVG Volume (30 Days) | ★ 1.7M | 923.9K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.11 | ★ 382.18 |
| EPS | N/A | ★ 4.87 |
| Revenue | $457,547,000.00 | ★ $605,494,000.00 |
| Revenue This Year | $9.03 | $24.51 |
| Revenue Next Year | $8.83 | $18.73 |
| P/E Ratio | ★ N/A | $20.97 |
| Revenue Growth | 12.72 | ★ 37.13 |
| 52 Week Low | $5.39 | $62.42 |
| 52 Week High | $24.74 | $156.00 |
| Indicator | SPT | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 34.90 | 24.72 |
| Support Level | N/A | N/A |
| Resistance Level | $7.39 | $131.86 |
| Average True Range (ATR) | 0.31 | 5.48 |
| MACD | 0.06 | -2.58 |
| Stochastic Oscillator | 17.12 | 3.82 |
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.